Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma

Stephen P. Malkoski, Sarah M. Haeger, Timothy G. Cleaver, Karen J. Rodriguez, Howard Li, Shi Long Lu, William J. Feser, Anna E. Barón, Daniel Merrick, Jessyka Lighthall, Hideaki Ijichi, Wilbur Franklin, Xiao Jing Wang

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose: Lung adenocarcinoma and lung squamous cell carcinoma (SCC) are the most common non-small cell lung cancer (NSCLC) subtypes. This study was designed to determine whether reduced expression of TGFβ type II receptor (TGFβRII) promotes lung adenocarcinoma and SCC carcinogenesis. Experimental Design: We examined TGFβRII expression at the protein and mRNA levels in human NSCLC samples and assessed the relationship between TGFβRII expression and clinicopathologic parameters. To determine whether sporadic TGFβRII deletion in airway epithelial cells induces NSCLC formation, we targeted TGFβRII deletion alone and in combination with oncogenic Kras G12D to murine airways using a keratin 5 (K5) promoter and inducible Cre recombinase. Results: Reduced TGFβRII expression in human NSCLC is associated with male gender, smoking, SCC histology, reduced differentiation, increased tumor stage, increased nodal metastasis, and reduced survival. Homozygous or heterozygous TGFβRII deletion in mouse airway epithelia increases the size and number of Kras G12D-initiated adenocarcinoma and SCC. TGFβRII deletion increases proliferation, local inflammation, and TGFβ ligand elaboration; TGFβRII knockdown in airway epithelial cells increases migration and invasion. Conclusions: Reduced TGFβRII expression in human NSCLC is associated with more aggressive tumor behavior and inflammation that is, at least partially, mediated by increased TGFβ1 expression. TGFβRII deletion in mouse airway epithelial cells promotes adenocarcinoma and SCC formation, indicating that TGFβRII loss plays a causal role in lung carcinogenesis. That TGFβRII shows haploid insufficiency suggests that a 50% TGFβRII protein reduction would negatively impact lung cancer prognosis.

Original languageEnglish (US)
Pages (from-to)2173-2183
Number of pages11
JournalClinical Cancer Research
Volume18
Issue number8
DOIs
StatePublished - Apr 15 2012

Fingerprint

Non-Small Cell Lung Carcinoma
Squamous Cell Carcinoma
Survival
Epithelial Cells
Neoplasms
Carcinogenesis
Adenocarcinoma
Keratin-5
Inflammation
Haploidy
Cell Movement
Lung Neoplasms
Histology
Proteins
Research Design
Epithelium
Smoking
transforming growth factor-beta type II receptor
Adenocarcinoma of lung
Neoplasm Metastasis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Malkoski, Stephen P. ; Haeger, Sarah M. ; Cleaver, Timothy G. ; Rodriguez, Karen J. ; Li, Howard ; Lu, Shi Long ; Feser, William J. ; Barón, Anna E. ; Merrick, Daniel ; Lighthall, Jessyka ; Ijichi, Hideaki ; Franklin, Wilbur ; Wang, Xiao Jing. / Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. In: Clinical Cancer Research. 2012 ; Vol. 18, No. 8. pp. 2173-2183.
@article{7fd069a77a3a4da3b3db8703fdb54579,
title = "Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma",
abstract = "Purpose: Lung adenocarcinoma and lung squamous cell carcinoma (SCC) are the most common non-small cell lung cancer (NSCLC) subtypes. This study was designed to determine whether reduced expression of TGFβ type II receptor (TGFβRII) promotes lung adenocarcinoma and SCC carcinogenesis. Experimental Design: We examined TGFβRII expression at the protein and mRNA levels in human NSCLC samples and assessed the relationship between TGFβRII expression and clinicopathologic parameters. To determine whether sporadic TGFβRII deletion in airway epithelial cells induces NSCLC formation, we targeted TGFβRII deletion alone and in combination with oncogenic Kras G12D to murine airways using a keratin 5 (K5) promoter and inducible Cre recombinase. Results: Reduced TGFβRII expression in human NSCLC is associated with male gender, smoking, SCC histology, reduced differentiation, increased tumor stage, increased nodal metastasis, and reduced survival. Homozygous or heterozygous TGFβRII deletion in mouse airway epithelia increases the size and number of Kras G12D-initiated adenocarcinoma and SCC. TGFβRII deletion increases proliferation, local inflammation, and TGFβ ligand elaboration; TGFβRII knockdown in airway epithelial cells increases migration and invasion. Conclusions: Reduced TGFβRII expression in human NSCLC is associated with more aggressive tumor behavior and inflammation that is, at least partially, mediated by increased TGFβ1 expression. TGFβRII deletion in mouse airway epithelial cells promotes adenocarcinoma and SCC formation, indicating that TGFβRII loss plays a causal role in lung carcinogenesis. That TGFβRII shows haploid insufficiency suggests that a 50{\%} TGFβRII protein reduction would negatively impact lung cancer prognosis.",
author = "Malkoski, {Stephen P.} and Haeger, {Sarah M.} and Cleaver, {Timothy G.} and Rodriguez, {Karen J.} and Howard Li and Lu, {Shi Long} and Feser, {William J.} and Bar{\'o}n, {Anna E.} and Daniel Merrick and Jessyka Lighthall and Hideaki Ijichi and Wilbur Franklin and Wang, {Xiao Jing}",
year = "2012",
month = "4",
day = "15",
doi = "10.1158/1078-0432.CCR-11-2557",
language = "English (US)",
volume = "18",
pages = "2173--2183",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

Malkoski, SP, Haeger, SM, Cleaver, TG, Rodriguez, KJ, Li, H, Lu, SL, Feser, WJ, Barón, AE, Merrick, D, Lighthall, J, Ijichi, H, Franklin, W & Wang, XJ 2012, 'Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma', Clinical Cancer Research, vol. 18, no. 8, pp. 2173-2183. https://doi.org/10.1158/1078-0432.CCR-11-2557

Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. / Malkoski, Stephen P.; Haeger, Sarah M.; Cleaver, Timothy G.; Rodriguez, Karen J.; Li, Howard; Lu, Shi Long; Feser, William J.; Barón, Anna E.; Merrick, Daniel; Lighthall, Jessyka; Ijichi, Hideaki; Franklin, Wilbur; Wang, Xiao Jing.

In: Clinical Cancer Research, Vol. 18, No. 8, 15.04.2012, p. 2173-2183.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma

AU - Malkoski, Stephen P.

AU - Haeger, Sarah M.

AU - Cleaver, Timothy G.

AU - Rodriguez, Karen J.

AU - Li, Howard

AU - Lu, Shi Long

AU - Feser, William J.

AU - Barón, Anna E.

AU - Merrick, Daniel

AU - Lighthall, Jessyka

AU - Ijichi, Hideaki

AU - Franklin, Wilbur

AU - Wang, Xiao Jing

PY - 2012/4/15

Y1 - 2012/4/15

N2 - Purpose: Lung adenocarcinoma and lung squamous cell carcinoma (SCC) are the most common non-small cell lung cancer (NSCLC) subtypes. This study was designed to determine whether reduced expression of TGFβ type II receptor (TGFβRII) promotes lung adenocarcinoma and SCC carcinogenesis. Experimental Design: We examined TGFβRII expression at the protein and mRNA levels in human NSCLC samples and assessed the relationship between TGFβRII expression and clinicopathologic parameters. To determine whether sporadic TGFβRII deletion in airway epithelial cells induces NSCLC formation, we targeted TGFβRII deletion alone and in combination with oncogenic Kras G12D to murine airways using a keratin 5 (K5) promoter and inducible Cre recombinase. Results: Reduced TGFβRII expression in human NSCLC is associated with male gender, smoking, SCC histology, reduced differentiation, increased tumor stage, increased nodal metastasis, and reduced survival. Homozygous or heterozygous TGFβRII deletion in mouse airway epithelia increases the size and number of Kras G12D-initiated adenocarcinoma and SCC. TGFβRII deletion increases proliferation, local inflammation, and TGFβ ligand elaboration; TGFβRII knockdown in airway epithelial cells increases migration and invasion. Conclusions: Reduced TGFβRII expression in human NSCLC is associated with more aggressive tumor behavior and inflammation that is, at least partially, mediated by increased TGFβ1 expression. TGFβRII deletion in mouse airway epithelial cells promotes adenocarcinoma and SCC formation, indicating that TGFβRII loss plays a causal role in lung carcinogenesis. That TGFβRII shows haploid insufficiency suggests that a 50% TGFβRII protein reduction would negatively impact lung cancer prognosis.

AB - Purpose: Lung adenocarcinoma and lung squamous cell carcinoma (SCC) are the most common non-small cell lung cancer (NSCLC) subtypes. This study was designed to determine whether reduced expression of TGFβ type II receptor (TGFβRII) promotes lung adenocarcinoma and SCC carcinogenesis. Experimental Design: We examined TGFβRII expression at the protein and mRNA levels in human NSCLC samples and assessed the relationship between TGFβRII expression and clinicopathologic parameters. To determine whether sporadic TGFβRII deletion in airway epithelial cells induces NSCLC formation, we targeted TGFβRII deletion alone and in combination with oncogenic Kras G12D to murine airways using a keratin 5 (K5) promoter and inducible Cre recombinase. Results: Reduced TGFβRII expression in human NSCLC is associated with male gender, smoking, SCC histology, reduced differentiation, increased tumor stage, increased nodal metastasis, and reduced survival. Homozygous or heterozygous TGFβRII deletion in mouse airway epithelia increases the size and number of Kras G12D-initiated adenocarcinoma and SCC. TGFβRII deletion increases proliferation, local inflammation, and TGFβ ligand elaboration; TGFβRII knockdown in airway epithelial cells increases migration and invasion. Conclusions: Reduced TGFβRII expression in human NSCLC is associated with more aggressive tumor behavior and inflammation that is, at least partially, mediated by increased TGFβ1 expression. TGFβRII deletion in mouse airway epithelial cells promotes adenocarcinoma and SCC formation, indicating that TGFβRII loss plays a causal role in lung carcinogenesis. That TGFβRII shows haploid insufficiency suggests that a 50% TGFβRII protein reduction would negatively impact lung cancer prognosis.

UR - http://www.scopus.com/inward/record.url?scp=84859862408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859862408&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-11-2557

DO - 10.1158/1078-0432.CCR-11-2557

M3 - Article

VL - 18

SP - 2173

EP - 2183

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -